95% Swertiamarin Swertia Chirata Extract Natural Antioxidant

Swertia is a genus in the gentian family. Swertiamarin is used as an active ingredient derived from Swertiapatens (Swertia davida or Swertia bimaculata). Swertiamarin is a representative constituent of many crude drugs, which are marketed in Japan and other countries and these crude drugs are normally evaluated by their high swertiamarin content (Takei et al., 2001). It has very low toxicity and is a safe and effective antispastic agent. It showed sedative effect in mice, pigeons and rabbits and induced sleep in mice (Mandal et al., 1998). Its antibacterial, brine shrimp lethality and anticholinergic activities were also reported (Kumarsamy et al., 2003). The study results prove that swertiamarin possess both peripheral and central antinociceptive activity. Swertiamarin are being used to relieve pain. It mainly treats the hepatitis, Oxidation resistance, Antivirus,Increase Immune Function.

Swertiamarin, a secoiridoid glycoside, is identified as the lead compound that confers anti-hyperglycemic & anti-hyperlipidemic effects. The swertiamarin binds with one or more molecular targets to alter their expression and/or activity.

Swertiamarin has been shown to exert beneficial effects in several models of diabetes mellitus and cardiovascular diseases. The mechanism by which swertiamarin reduces diabetes includes a reduction in blood glucose, HbA1c, total cholesterol, triglycerides, LDL levels and elevation in body weight and plasma insulin, HDL levels as well an increase the insulin sensitivity index. It also decreases the SGOT, SGPT and serum ALP activities. Further, it significantly decreased serum urea and creatinine and other parameters associated with the development of diabetes mellitus.

1. Rebuild liver cell and improve circulation of liver
2. Prevent hepatitis from Galt
3. Antioxidant
4. Improve immune function
5. Anticancer: Swertiamarin exerts anticancer effects on human cervical cancer cells via induction of apoptosis, inhibition of cell migration and targeting of MEK-ERK pathway
6. Swertiamarin has been reported to have high anti-atherogenic, cholesterol-lowering potential and inhibition of HMG-Co-A reductase.
7. Swertiamarin is effective in inhibiting α-amylase and α-glucosidase.
8. Anti-inflammatory.